STERIS CORP Deferred Tax Expense from Stock Options Exercised
STERIS CORP reported Deferred Tax Expense from Stock Options Exercised of $11.53 million for the 12-month period ending 2015-03-31, per its 10-K filed 2015-05-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2015-05-27
- STERIS CORP deferred tax expense from stock options exercised for fiscal 2015 was $11.53M, a 305.70% increase from fiscal 2014.
- STERIS CORP deferred tax expense from stock options exercised for fiscal 2014 was $2.84M, a 38.05% increase from fiscal 2013.
- STERIS CORP deferred tax expense from stock options exercised for fiscal 2013 was $2.06M, a 35.93% increase from fiscal 2012.
- STERIS CORP deferred tax expense from stock options exercised for fiscal 2012 was $1.51M.
| Period end | Deferred Tax Expense from Stock Options Exercised 12 month |
|---|---|
| 2015-03-31 | $11.53M 10-K · filed 2015-05-27 |
| 2014-03-31 | $2.84M 10-K · filed 2015-05-27 |
| 2013-03-31 | $2.06M 10-K · filed 2015-05-27 |
| 2012-03-31 | $1.51M 10-K · filed 2014-05-29 |